NIAID Banner Logo Image


1. 59481 HIV-LS-362; PUBMED-HIV-11/27/2006

Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines

Balzarini, J, Schols, D, Van Laethem, K, De Clercq, E, Hockova, D, Masojidkova, M, and Holy, A

J Antimicrob Chemother 2006.


2. 59482 HIV-LS-362; PUBMED-HIV-11/27/2006

Synthesis of novel benzofuran and related benzimidazole derivatives for evaluation of in vitro anti-HIV-1, anticancer and antimicrobial activities

Rida, SM, El-Hawash, SA, Fahmy, HT, Hazzaa, AA, and El-Meligy, MM

Arch Pharm Res 2006. 29(10): 826-33


3. 59483 HIV-LS-362; PUBMED-HIV-11/27/2006

A Rationally Designed Synthetic Mimic of the Discontinuous CD4-Binding Site of HIV-1 gp120

Franke, R, Hirsch, T, and Eichler, J

J Recept Signal Transduct Res 2006. 26(5): 453-60


4. 59484 HIV-LS-362; PUBMED-HIV-11/27/2006

Cytotoxic and Anti-HIV-1 Caged Xanthones from the Resin and Fruits of Garcinia hanburyi

Reutrakul, V, Anantachoke, N, Pohmakotr, M, Jaipetch, T, Sophasan, S, Yoosook, C, Kasisit, J, Napaswat, C, Santisuk, T, and Tuchinda, P

Planta Med 2006.


5. 59485 HIV-LS-362; PUBMED-HIV-11/27/2006

A Novel Non-nucleoside Analogue That Inhibits HIV-1 Isolates Resistant to Current Non-Nucleoside RT Inhibitors

Zhang, Z, Xu, W, Koh, YH, Shim, JH, Girardet, JL, Yeh, LT, Hamatake, RK, and Hong, Z

Antimicrob Agents Chemother 2006.


6. 59486 HIV-LS-362; PUBMED-HIV-11/27/2006

Isolation and Characterization of Human Immunodeficiency Virus Type 1 Resistant to the Small-Molecule CCR5 Antagonist TAK-652

Baba, M, Miyake, H, Wang, X, Okamotoand, M, and Takashima, K

Antimicrob Agents Chemother 2006.


7. 59487 HIV-LS-362; PUBMED-HIV-11/27/2006

Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Hang, JQ, Li, Y, Yang, Y, Cammack, N, Mirzadegan, T, and Klumpp, K

Biochem Biophys Res Commun 2006.


8. 59488 HIV-LS-362; PUBMED-HIV-11/27/2006

A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa

Wang, J, Wang, HX, and Ng, TB

Peptides 2006.


9. 59489 HIV-LS-362; EMBASE-HIV-11/26/2006

Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations

Aruksakunwong, Ornjira, Wittayanarakul, Kitiyaporn, Sompornpisut, Pornthep, Sanghiran, Vannajan, Parasuk, Vudthichai, and Hannongbua, Supot

Journal of Molecular Graphics and Modelling 2006. 25(3): 324-332


10. 59490 HIV-LS-362; PUBMED-HIV-11/27/2006

Highly selective action of triphosphate metabolite of 4'-ethynyl D4T: A novel anti-HIV compound against HIV-1 RT

Yang, G, Dutschman, GE, Wang, CJ, Tanaka, H, Baba, M, Anderson, KS, and Cheng, YC

Antiviral Res 2006.


11. 59491 HIV-LS-362; PUBMED-HIV-11/27/2006

Amino Acid Conjugated Sophorolipids: A New Family of Biologically Active Functionalized Glycolipids

Azim, A, Shah, V, Doncel, GF, Peterson, N, Gao, W, and Gross, R

Bioconjug Chem 2006. 17(6): 1523-1529


12. 59492 HIV-LS-362; PUBMED-HIV-11/27/2006

Protease inhibitors and their peptidomimetic derivatives as potential drugs

Fear, G, Komarnytsky, S, and Raskin, I

Pharmacol Ther 2006.


13. 59493 HIV-LS-362; EMBASE-HIV-11/26/2006

Crystal Structures of Clinically Relevant Lys103Asn/Tyr181Cys Double Mutant HIV-1 Reverse Transcriptase in Complexes with ATP and Non-nucleoside Inhibitor HBY 097

Das, Kalyan, Sarafianos, Stefan G, Clark, Jr Arthur D, Boyer, Paul L, Hughes, Stephen H, and Arnold, Eddy

Journal of Molecular Biology 2006. In Press, Corrected Proof


14. 59494 HIV-LS-362; PUBMED-HIV-11/27/2006

Virological and clinical implications of resistance to HIV-1 protease inhibitors

Condra, JH

Drug Resist Updat 1998. 1(5): 292-9


15. 59495 HIV-LS-362; PUBMED-HIV-11/27/2006

Kalanchosides A-C, new cytotoxic bufadienolides from the aerial parts of Kalanchoe gracilis

Wu, PL, Hsu, YL, Wu, TS, Bastow, KF, and Lee, KH

Org Lett 2006. 8(23): 5207-10


16. 59496 HIV-LS-362; PUBMED-HIV-11/27/2006

Etravirine: R165335, TMC 125, TMC-125, TMC125


Drugs R D 2006. 7(6): 367-373


17. 59497 HIV-LS-362; PUBMED-HIV-11/27/2006

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

Chou, R, Fu, R, Huffman, LH, and Korthuis, PT

Lancet 2006. 368(9546): 1503-15


18. 59498 HIV-LS-362; EMBASE-HIV-11/26/2006

Establishment of a new cell line inducibly expressing HIV-1 protease for performing safe and highly sensitive screening of HIV protease inhibitors

Fuse, Takayuki, Watanabe, Ken, Kitazato, Kaio, and Kobayashi, Nobuyuki

Microbes and Infection 2006. 8(7): 1783-1789


19. 59499 HIV-LS-362; EMBASE-HIV-11/26/2006

Anti-HIV drugs and the mitochondria: 14th European Bioenergetics Conference

Pinti, Marcello, Salomoni, Paolo, and Cossarizza, Andrea

Biochimica et Biophysica Acta (BBA) - Bioenergetics 2006. 1757(5-6): 700-707


20. 59500 HIV-LS-362; WOS-HIV-11/19/2006

Research of siRNA inhibition effect in HIV-1 gene expression

Wei, L, Liu, X, and Cao, C



21. 59501 HIV-LS-362; WOS-HIV-11/19/2006

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

Dang, Y, Wang, XJ, Esselman, WJ, and Zheng, YH

JOURNAL OF VIROLOGY 2006. 80(21): 10522-10533, 12


22. 59502 HIV-LS-362; WOS-HIV-11/26/2006

Synthesis of novel L-N-MCd4T as a potent anti-HIV agent

Park, AY, Moon, HR, Kim, KR, Chun, MW, and Jeong, LS

ORGANIC & BIOMOLECULAR CHEMISTRY 2006. 4(22): 4065-4067, 3


23. 59503 HIV-LS-362; WOS-HIV-11/26/2006

In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat)

Adamson, CS, Ablan, SD, Boeras, I, Goila-Gaur, R, Soheilian, F, Nagashima, K, Li, F, Salzwedel, K, Sakalian, M, Wild, CT, and Freed, EO

JOURNAL OF VIROLOGY 2006. 80(22): 10957-10971, 15


24. 59504 HIV-LS-362; WOS-HIV-11/26/2006

Pertussis toxin and its binding unit inhibit HIV-1 infection of human cervical tissue and macrophages involving a CD14 pathway

Hu, QX, Younson, J, Griffin, GE, Kelly, C, and Shattock, RJ

JOURNAL OF INFECTIOUS DISEASES 2006. 194(11): 1547-1556, 10


25. 59505 HIV-LS-362; WOS-HIV-11/26/2006

Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection

Nagy, G, Ward, J, Mosser, DD, Koncz, A, Gergely, P, Stancato, C, Qian, YM, Fernandez, D, Niland, B, Grossman, CE, Telarico, T, Banki, K, and Perl, A

JOURNAL OF BIOLOGICAL CHEMISTRY 2006. 281(45): 34574-34591, 18


26. 59506 HIV-LS-362; WOS-HIV-11/26/2006

Synthesis of 4/5-deoxy-4/5-nucleobase derivatives of 3-O-methyl-D-chiro-inositol as potential antiviral agents

Zhan, TR, Ma, YD, Fan, PH, Ji, M, and Lou, HX

CHEMISTRY & BIODIVERSITY 2006. 3(10): 1126-1137, 12


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2023